Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

57
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
57
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

56
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
56
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

62
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
62
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

89
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
89
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

78
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
78
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

82
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
82

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The EACTS Innovation Committee's Perspective on the "Heart Valve of the Future".

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Medium-term outcomes of aortic valve-sparing procedure in trileaflet valve: Longitudinal analysis from the Heart Valve Society Registry.

JTCVS structural and endovascular·2026
Same author

Managing asymmetry in bicuspid aortic valve repair: A case-based illustration.

JTCVS structural and endovascular·2026
Same author

Systolic doming or 'hockey-stick sign' of the aortic valve in rheumatic valve disease.

Journal of visualized surgery·2026
Same author

Aortic homografts for native and prosthetic aortic valve and root endocarditis: Results from the EUropean REgistry of Cryopreserved Aortic Homografts EURECAH.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Valve-sparing Aortic Root Replacement: Defining High-volume Centres Using Prospective Data.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026

Related Experiment Video

Updated: Oct 24, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.9K

Mitral valve repair for endocarditis.

Silvia Solari1, Emiliano Navarra1, Laurent de Kerchove1

  • 1Cardiovascular and Thoracic Surgery Department, Saint Luc University Clinic, Brussels, Belgium.

Journal of Cardiac Surgery
|August 14, 2021
PubMed
Summary

An early, repair-focused surgical approach improves mitral valve repair rates for infective endocarditis. This strategy offers good long-term durability and low recurrence, enhancing patient outcomes in complex cases.

Keywords:
cardiovascular pathologyendocarditismitral valvevalve repair/replacement

More Related Videos

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.1K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.7K

Related Experiment Videos

Last Updated: Oct 24, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.9K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.1K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.7K

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Infectious Diseases

Background:

  • Mitral valve repair (MVr) in infective endocarditis (IE) has historically low reparability rates.
  • Infective endocarditis presents challenges in surgical management due to its insidious nature.

Purpose of the Study:

  • To describe institutional experience with mitral valve repair for infective endocarditis.
  • To evaluate the efficacy of an early and repair-oriented surgical approach for IE.
  • To assess long-term outcomes of mitral valve repair in patients with infective endocarditis.

Main Methods:

  • Retrospective analysis of 160 consecutive patients undergoing mitral valve surgery for active IE on native MV from 1991 to 2015.
  • Data extracted from an institutional heart valve disease database.
  • Median follow-up of 122 months.

Main Results:

  • Hospital mortality was 11.6%. Early reoperation was required in 3.1% of patients.
  • Overall survival at 5, 10, and 15 years was 79%, 65%, and 57%, respectively.
  • Freedom from reoperation at 5, 10, and 15 years was 95%, 88%, and 81%, respectively.

Conclusions:

  • An early and repair-oriented surgical strategy can improve mitral valve repair rates in infective endocarditis.
  • This approach demonstrates good long-term durability and a low recurrence rate of endocarditis.
  • Mitral valve repair for infective endocarditis is feasible and yields favorable long-term results with appropriate surgical timing and technique.